Creating a drug that might help treat or cure a health condition in humans is a long, complex process. After developing a ...
SES AI earns a Strong Buy rating for its pivot from battery manufacturing to a high-margin SaaS and IP-driven model in the EV ...
ATRIMED’s work is driven by a women-led leadership and research culture that emphasizes interdisciplinary collaboration and long-term scientific investment. From data curation to algorithm development ...
A team of UC Santa Barbara engineering and molecular biology graduate students has developed software to accelerate the discovery process for therapies ...
Scientists are exploring pig skin to gain a fuller understanding of how this process works. The result could mean uncovering ...
SLNB remains a key staging procedure in clinically node-negative melanoma and provides prognostic information that can guide adjuvant therapy discussions. Current NCCN guidelines recommend discussing ...
MIT researchers have discovered that two common genetic mutations that cause Rett syndrome each set off a molecular chain of events that compromises the structural integrity of developing brain blood ...
The partnership integrates high-resolution multi-omics data generation with predictive multimodal machine learning to support biopharma decision-making in neurology.SALT LAKE CITY, Feb. 24, ...
Growing tissues can crack, break, and dissociate to form structures that can later withstand immense forces.
Chemical biomarkers are measurable molecular signatures (host immune markers, pathogen metabolites, volatile organic ...
Overview Artificial intelligence seems to be transforming drug discovery in 2026, enabling faster molecule design, smarter clinical trials, and reduced R&D ...
And now they’re launching it by way of their startup, ProFoldBio — one of nearly 70 startups that have emerged from UCSB’s New Venture Program — making the software available to other researchers in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results